Potent inhibition of Norwalk virus by cyclic sulfamide derivatives
- 15 October 2011
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (20) , 5975-5983
- https://doi.org/10.1016/j.bmc.2011.08.054
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C proteaseBioorganic & Medicinal Chemistry Letters, 2011
- Biodegradable nanogels for oral delivery of interferon for norovirus infectionAntiviral Research, 2011
- Antiviral strategies to control calicivirus infectionsAntiviral Research, 2010
- Noroviruses: State of the ArtFood and Environmental Virology, 2010
- Role of Cholesterol Pathways in Norovirus ReplicationJournal of Virology, 2009
- The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008)Expert Opinion on Therapeutic Patents, 2009
- Histone Deacetylase Inhibitors through Click ChemistryJournal of Medicinal Chemistry, 2008
- Interferons and Ribavirin Effectively Inhibit Norwalk Virus Replication in Replicon-Bearing CellsJournal of Virology, 2007
- Novel lβ-methylcarbapenems having cyclic sulfonamide moieties: Synthesis and evaluation of in vitro antibacterial activityEuropean Journal of Medicinal Chemistry, 2007
- Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine .beta.-hydroxylase. 4. Structure-activity relationships at the copper binding siteJournal of Medicinal Chemistry, 1990